ASPECTE DE FARMACOCINETICĂ PRIVIND PRODUSUL AUGMENTIN BIS

December 1, 1998

E. Manolescu *
* Prof. Dr. Emanoil Manolescu – Catedra de Farmacologie U.M.F, Carol Davila, Bucureşti

Abstract

The pharmacokinetic aspects of the amoxicil lin – clavulonat association, including a comparison between the Augmentin bis formula (7/1 x b.i.d) and the Augmentin formula (4/1 x t.i.d.) are presented. lt results the advantages of the Augmentin bis formula, especially in pediatric conditions.

Previous Story

KLACID, ANTIBIOTIC DE PRIMĂ INTENŢIE ÎN INFECŢIILE ACUTE RESPIRATORII LA COPIL

Next Story

TRATAMENTUL CU AMOXICILINĂ – ACID CLAVULANIC – FORMULA BIS